Bioniche third-one fourth consolidated revenues increase 111 percent to $15 cialis action.

Bioniche third-one fourth consolidated revenues increase 111 percent to $15 cialis action .6 million – consolidated revenues for the one fourth totalled $15.6 million including $9.5 million in licensing revenues – Bioniche Lifestyle Sciences Inc. , a research-based, technology-powered Canadian biopharmaceutical company, announced financial results because of its Fiscal 2010 third one fourth today, ended March 31, 2010. ‘The 3rd one fourth was another solid one for our Firm where further income was produced through licensing revenues from our U.S. Pharmaceutical partner in addition to revenues from animal wellness revenue,’ mentioned Graeme McRae, Chairman, President & CEO of Bioniche Lifestyle Sciences Inc.